Shares of Taysha Gene Therapies were down more than 10 percent after a patient’s death marred positive interim data for the company’s experimental gene therapy treatment for Sandhoff and Tay-Sachs diseases, which are two forms of GM2 gangliosidosis.
23andMe launches new consumer test service to check for genetic disorders
Alzheimer's, Alzheimer's Diseases, Bloom's Syndrome, Breast Cancer, Consumer Genetic Test Services, Cystic Fibrosis, DTC, FDA, Freckles, Genes, Genetic Disorders, Genetics, Hair Curliness, Health, Heart Conditions, Lactose Intolerance, Oncology, Ovarian Cancer, Sickle Cell Anemia, Tay-Sachs Disease, Tests, Thalassemia, Venture CapitalGenetics company 23andMe announced the launch of a new consumer genetic test service on Wednesday that will show whether an individual carries genes associated with 36 different disorders, such as […]